XENE
Xenon Pharmaceuticals Inc
36.90$
-2.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +43.8% | -4.7% | -3.8% | -5.4% | -4.5% | -6.9% | -9.3% | -9.9% | +61.5% | +41.3% | -6.6% | |
| – | +21.5% | +9.7% | +3.0% | -9.4% | -3.7% | -11.0% | -11.5% | -4.0% | +16.8% | +97.4% | -14.5% | |
| – | +49.3% | -60.4% | +132.2% | -35.9% | +62.9% | -18.3% | +16.1% | -22.8% | +90.6% | +174.1% | -78.1% | |
| – | +21.2% | +9.6% | +3.1% | -9.4% | -4.1% | -12.3% | -11.3% | -5.2% | +18.7% | +99.4% | -15.0% | |
| – | +8.6% | -4.7% | +2.4% | +10.0% | +56.6% | +488.8% | -87.3% | -26.0% | +68.8% | -15.0% | +39.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.9% | -15.1% | +27.6% | -4.7% | +13.5% | -9.1% | +2.5% | +19.9% | +727.5% | -87.7% | +9.0% | |
| – | +10.2% | -18.5% | +40.8% | -5.1% | +19.9% | -10.0% | +3.2% | +16.0% | +9.0% | -4.7% | +13.0% | |
| – | +4.3% | +1.8% | +2.3% | +2.4% | -1.3% | +0.9% | +5.6% | +2.5% | +2.5% | +1.9% | -14.3% | |
| – | +41.0% | -25.2% | +47.7% | -42.9% | -6.5% | +35.7% | -30.4% | -4.9% | -14.7% | +48.0% | -56.8% | |
| – | +45.8% | -4.3% | -4.9% | -5.5% | -5.4% | -6.7% | -9.9% | -11.7% | +4.0% | +130.0% | -7.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.0% | +10.9% | +0.1% | +0.3% | +0.6% | +0.4% | +0.3% | +0.4% | +0.0% | +10.2% | +14.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.